FDA warns Rise N’ Shine Farm after inspection found Salmonella Enteritidis and shell egg safety violations at its Georgia farm.
What happened
FDA inspected Rise N’ Shine Farm’s shell egg farm and egg washing and packing facility in Calhoun, Georgia, from October 23 to 27, 2023, and found violations of the shell egg safety rule plus sanitation problems. Swabs detected Salmonella Enteritidis in poultry-house manure and dust and in a drain below the egg candler; DNA matching showed the strains matched many human illness isolates. The company later reported a positive Salmonella Enteritidis egg test on January 11, 2024, during required egg testing.
What FDA found
The farm did not have or implement a written Salmonella Enteritidis prevention plan specific to the farm with the required minimum measures.
21 CFR 118.4The farm did not test the pullet environment for Salmonella Enteritidis when pullets were 14 to 16 weeks old.
21 CFR 118.4(a)(2)(i)The farm did not test the laying hen house for Salmonella Enteritidis when the hens were 40 to 45 weeks old.
21 CFR 118.5(a)The farm did not keep dogs and other animals out of the poultry house.
21 CFR 118.4(b)(4)The farm did not register with FDA as a shell egg producer even though it had 3,000 or more laying hens and was not selling all eggs directly to consumers.
21 CFR 118.11(a)Eggs were prepared, packed, or held under insanitary conditions, including grime on the candling line, rust near food-contact points, dirty brushes, porous wood, and duct tape on the packing line touching shell eggs.
FD&C Act section 402(a)(4), 21 U.S.C. § 342(a)(4)
What FDA wants
Within 15 working days of receiving the letter, notify FDA in writing of the specific steps taken to correct the violations and prevent recurrence, with related documentation. If corrections cannot be completed in that time, state the reason for delay and the timeframe for completion.
Who should pay attention
- egg distributors and retailers
- foodservice operators that buy shell eggs
- contract packers and egg processors
This is a summary. Read the original letter on fda.gov.